173 related articles for article (PubMed ID: 36551684)
1. HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients.
Lu Y; Zhu S; Tong Y; Fei X; Jiang W; Shen K; Chen X
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551684
[TBL] [Abstract][Full Text] [Related]
2. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.
Chen X; Sun L; Mao Y; Zhu S; Wu J; Huang O; Li Y; Chen W; Wang J; Yuan Y; Fei X; Jin X; Shen K
BMC Cancer; 2013 Aug; 13():390. PubMed ID: 23957561
[TBL] [Abstract][Full Text] [Related]
3. Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status.
Na S; Kim M; Park Y; Kwon HJ; Shin HC; Kim EK; Jang M; Kim SM; Park SY
Breast Cancer; 2024 Jul; 31(4):705-716. PubMed ID: 38643429
[TBL] [Abstract][Full Text] [Related]
4. Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.
Shanmugalingam A; Hitos K; Hegde S; Al-Mashat A; Pathmanathan N; Edirimmane S; Hughes TM; Ngui NK
Breast Cancer Res Treat; 2022 May; 193(1):151-159. PubMed ID: 35229238
[TBL] [Abstract][Full Text] [Related]
5. How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer.
Saghir H; Veerla S; Malmberg M; Rydén L; Ehinger A; Saal LH; Vallon-Christersson J; Borg Å; Hegardt C; Larsson C; Haidar A; Hedenfalk I; Loman N; Kimbung S
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010992
[TBL] [Abstract][Full Text] [Related]
6. HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens.
Tsuda H; Kurosumi M; Umemura S; Yamamoto S; Kobayashi T; Osamura RY
BMC Cancer; 2010 Oct; 10():534. PubMed ID: 20925963
[TBL] [Abstract][Full Text] [Related]
7. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
Chen X; Yuan Y; Gu Z; Shen K
Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study on Level of Concordance Between Core Needle Biopsy and Surgical Specimen for Assessing Oestrogen Receptor, Progesterone Receptor, and Her2/Neu Receptor Status in Carcinoma Breast and Its Implications on Treatment Decisions.
Damodaran D; Naidu BK; Varghese JC; Rajan P; Kuruvilla R; Kuruvilla S; Kavitha KP
Indian J Surg Oncol; 2020 Sep; 11(3):446-450. PubMed ID: 33013125
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population.
Chen R; Qi Y; Huang Y; Liu W; Yang R; Zhao X; Wu Y; Li Q; Wang Z; Sun X; Wei B; Chen J
Breast Cancer Res Treat; 2023 Jan; 197(1):189-200. PubMed ID: 36346486
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.
Zeng J; Piscuoglio S; Aggarwal G; Magda J; Friedlander MA; Murray M; Akram M; Reis-Filho JS; Weigelt B; Edelweiss M
Cancer Cytopathol; 2020 Feb; 128(2):133-145. PubMed ID: 31883437
[TBL] [Abstract][Full Text] [Related]
12. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
13. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
Chen X; Zhu S; Fei X; Garfield DH; Wu J; Huang O; Li Y; Zhu L; He J; Chen W; Jin X; Shen K
BMC Cancer; 2015 Oct; 15():822. PubMed ID: 26514283
[TBL] [Abstract][Full Text] [Related]
14. Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience.
Slostad JA; Yun NK; Schad AE; Warrior S; Fogg LF; Rao R
Cancer Med; 2022 Dec; 11(24):4954-4965. PubMed ID: 35733293
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry.
You K; Park S; Ryu JM; Kim I; Lee SK; Yu J; Kim SW; Nam SJ; Lee JE
J Breast Cancer; 2017 Sep; 20(3):297-303. PubMed ID: 28970856
[TBL] [Abstract][Full Text] [Related]
16. Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients.
Rodriguez C; Suciu V; Poterie A; Lacroix L; Miran I; Boichard A; Delaloge S; Deneuve J; Azoulay S; Mathieu MC; Valent A; Michiels S; Arnedos M; Vielh P
Mol Oncol; 2016 Nov; 10(9):1430-1436. PubMed ID: 27555543
[TBL] [Abstract][Full Text] [Related]
17. Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant.
Robertson S; Rönnlund C; de Boniface J; Hartman J
Breast Cancer Res Treat; 2019 Apr; 174(3):795-805. PubMed ID: 30659433
[TBL] [Abstract][Full Text] [Related]
18. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
Asogan AB; Hong GS; Arni Prabhakaran SK
Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
[TBL] [Abstract][Full Text] [Related]
19. Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
Dekker TJ; Smit VT; Hooijer GK; Van de Vijver MJ; Mesker WE; Tollenaar RA; Nortier JW; Kroep JR
Ann Oncol; 2013 Apr; 24(4):931-7. PubMed ID: 23211940
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer.
Jeong YS; Kang J; Lee J; Yoo TK; Kim SH; Lee A
J Pathol Transl Med; 2020 Jan; 54(1):87-94. PubMed ID: 31718121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
